Mechanisms, measurement and management of exertional dyspnoea in asthma: Number 5 in the Series "Exertional dyspnoea" Edited by Pierantonio Laveneziana and Piergiuseppe Agostoni

Eur Respir Rev. 2017 Jun 14;26(144):170015. doi: 10.1183/16000617.0015-2017. Print 2017 Jun 30.

Abstract

Asthma is a heterogeneous condition, with dyspnoea during exercise affecting individuals to a variable degree. This narrative review explores the mechanisms and measurement of exertional dyspnoea in asthma and summarises the available evidence for the efficacy of various interventions on exertional dyspnoea. Studies on the mechanisms of dyspnoea in asthma have largely utilised direct bronchoprovocation challenges, rather than exercise, which may invoke different physiological mechanisms. Thus, the description of dyspnoea during methacholine challenge can differ from what is experienced during daily activities, including exercise. Dyspnoea perception during exercise is influenced by many interacting variables, such as asthma severity and phenotype, bronchoconstriction, dynamic hyperinflation, respiratory drive and psychological factors. In addition to the intensity of dyspnoea, the qualitative description of dyspnoea may give important clues as to the underlying mechanism and may be an important endpoint for future interventional studies. There is currently little evidence demonstrating whether pharmacological or non-pharmacological interventions specifically improve exertional dyspnoea, which is an important area for future research.

Publication types

  • Review

MeSH terms

  • Activities of Daily Living
  • Asthma, Exercise-Induced / diagnosis*
  • Asthma, Exercise-Induced / drug therapy*
  • Asthma, Exercise-Induced / etiology
  • Asthma, Exercise-Induced / physiopathology
  • Bronchial Provocation Tests*
  • Bronchodilator Agents / adverse effects
  • Bronchodilator Agents / therapeutic use*
  • Dyspnea / diagnosis*
  • Dyspnea / drug therapy*
  • Dyspnea / etiology
  • Dyspnea / physiopathology
  • Humans
  • Lung / drug effects*
  • Lung / physiopathology
  • Predictive Value of Tests
  • Risk Factors
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Bronchodilator Agents